WuXi Healthcare Forum 2021
March 15, 2021

WuXi Healthcare Forum 2021

Date and time

March 15, 2021 ~ March 18, 2021

Dear Colleagues and Friends,


The much anticipated  WuXi Healthcare Forum 2021  premiered on March 15-18th. This complimentary and global event titled, “Partnership for Patients,” brought together 6,000+ registrations, 70+ distinguished speakers, and 200+ CEO Roundtable presenting companies all focused on the same goal – to advance breakthroughs faster for patients.


Global healthcare challenges require global partnership and global solutions. We hope WuXi Healthcare Forum further strengthens the global connections among us, and we look forward to welcoming you to future discussions of many important topics.


Special thanks to our supportive partners: Goldman Sachs, JP Morgan, Huatai Securities, China Renaissance, Qiming Venture Partners, Frost & Sullivan, Morgan Stanley, Great Britain & Northern Ireland, UK BioIndustry Association, Swiss Biotech Association, California Life Sciences Association, ChinaBio, Children’s Tumor Foundation, BioCentury, BioWorld, BayHelix, Endpoints News, MBC BioLabs, Pharma Intelligence | Informa, and QB3.

Agenda
  • March 15, 06:00 PM - March 16, 01:00 AM Path to a Collaborative Future

    6:00 – 6:05pm Welcome  

    Hui Cai, Forum Chair; VP and Head of Content Division, WuXi AppTec 


    6:05 – 6:15pm Opening Remarks

    Steve Yang, Co-CEO, WuXi AppTec

    Philip Ross, Vice Chairman, Global Investment Banking, J.P. Morgan


    6:15 – 6:45pm Shaping the Future of R&D

    James Bradner, President, Novartis Institutes for Biomedical Research 

    Andy Plump, President of R&D, Takeda

    Session Leader: Steve Yang, Co-CEO, WuXi AppTec


    6:45 – 7:40pm The World for Asia. Asia for the World.  

    Nisa Leung, Managing Partner, Qiming Ventures Partners

    Kevin Looi, Managing Director and Head of Asia, GIC Private Equity

    Leon Wang, EVP of International & China President, AstraZeneca

    Bernhardt Zeiher, CMO, Astellas Pharma

    Session Leader: Dan Wang, Head of Johnson & Johnson Innovation, Asia Pacific


    7:40 – 8:30pm Partnerships in Europe: An Inspiring Cross-Regional Discussion

    Casper Breum, Senior Advisor, Lundbeckfonden Ventures

    Geert-Jan Mulder, Managing Partner, Forbion

    Ena Prosser, Partner, Fountain Healthcare Partners

    Rafaèle Tordjman, Founder & CEO, Jeito Capital

    Session Leader: Mary Kerr, CEO, NeRRe Therapeutics


    BREAK


    10:00 – 11:30pm New Changes in Healthcare Industry: Capitalization, Innovation and

    Internationalization

    Partners’ Satellite Forum Hosted by Huatai Securities


    11:30 – 1:00am Global Healthcare Sector in Pandemic: Past, Present and Future

    Partners’ Satellite Forum Hosted by J.P. Morgan

  • March 16, 06:00 AM - 12:30 PM Global Solutions for Global Challenges: Part I

    6:00 – 8:00am CEO Roundtable Session I (invitation only)


    8:00 – 8:15am Welcome to Innovation Spotlight Part I

    A conversation on Global Solutions for Global Challenges with special guest Jenny Yip, Managing Partner, Adjuvant Capital

    Host: Richard Soll, Head of Boston Office and Senior Advisor of Strategic Initiatives, WuXi AppTec


    8:15 – 9:10am Germany: Translating Scientific Excellence

    Marianne De Backer, Head of Strategy, BD&L and Member of the Pharmaceuticals Executive Committee, Bayer

    Bernd Goergen, Partner, High-Tech Gruenderfonds

    Marcus Kostka, CEO, Abalos Therapeutics

    Ioannis Sapountzis, Corp. SVP and Global Head of BD&L, Boehringer Ingelheim

    Session Leader: Caroline Xu, Co-Founder & CEO, ViGeneron

     

    9:10 – 10:00am Switzerland: A Global Life Sciences Hub in the Heart of Europe

    Ulf Grawunder, CEO, NBE Therapeutics

    Chandra Leo, Investment Advisor, HBM Partners 

    Chris Martin, CEO, Co-Founder & Director, ADC Therapeutics

    Alex Mayweg, Managing Director, Versant Ventures

    Jordi Montserrat, Co-Founder & Managing Partner, Venturelab

    Session Leader: Michael Altorfer, CEO, Swiss Biotech Association


    10:00 – 10:10am A Special Musical Tribute to Patients  


    BREAK


    6:00 – 8:00pm CEO Roundtable Session II (invitation only)


    8:00 – 8:55pm South Korea’s Rising Roles in the Global Innovation Ecosystem  

    Kyoung Kim, EVP, CHA Biotech

    James Jungkue Lee, CEO, Bridge Biotherapeutics

    Lauren Young-Mi Lee, SVP, Head of Global R&D Innovation, Hanmi Pharmaceuticals

    Jin-San Yoo, President & CEO, PharmAbcine

    Session Leader: Chris Kim, Managing Director, Novatio Ventures


    8:55 – 9:50pm From Japan to Global: State of Innovation

    Sakae Asanuma, President, Taiho Ventures

    Mayu Morishima, Executive Officer & Biotech Lead Capitalist, Beyond Next Ventures

    Haru Morita, Chairman & CEO, Modalis Therapeutics

    Mark Noguchi, SVP and Head of Business Development, Chugai Pharmaceutical 

    Makoto (Mark) Ohori, Partner, UTokyo Innovation Platform 

    Aki Tobaru, Partner, Remiges Ventures

    Session Leader: Tai Harada, Manager & VP of US Operation, Fast Track Initiative


    9:50 – 10:00pm A Special Musical Tribute to Patients  


    10:00 – 11:00pm Global Healthcare Industry: Challenges and Opportunities (invitation only)

    Partners’ Satellite Forum Hosted by Goldman Sachs


    11:00 – 12:30am Healthcare Innovation under New Norms

    Partners’ Satellite Forum Hosted by China Renaissance

  • March 17, 07:00 AM - 10:10 PM Global Solutions for Global Challenges: Part II

    7:00 – 7:15am Welcome to Innovation Spotlight Part II

    A conversation on Global Solutions for Global Challenges with special guest Laurent Fraisse, R&D Director, Drugs for Neglected Diseases Initiative (DNDi)

    Host: Dave Madge, VP of Research Service Division, WuXi AppTec

      

    7:15 – 8:05am New Models of Therapeutic Innovation in UK 

    Julie Brady, Business Development Manager for Drug Discovery, University of Dundee

    Kathryn Chapman, Deputy Director, Milner Therapeutics Institute, University of Cambridge

    Chris Molloy, CEO, Medicines Discovery Catapult

    James Naismith, Director, Rosalind Franklin Institute; Professor, Structural Biology, University of Oxford

    Session Leader: Ian Tomlinson, Chairman, Apollo Therapeutics; Chairman, Start Codon


    8:05 – 9:05am Ireland, an Innovative Global Leader in the Digitalised Life Sciences Sector

    Martin Shanahan, CEO, IDA Ireland 

    Barry Heavey, Managing Director, Accenture Life Sciences

    Darrin Morrissey, Chief Executive of the National Institute for Bioprocessing Research and Training, Ireland

    Session Leaders: Emmanuel Dowdall, Global EVP and CEO Asia Pacific, IDA Ireland


    9:05 – 9:15am A Special Musical Tribute to Patients  


    BREAK


    6:00 – 8:00pm CEO Roundtable Session III (invitation only)


    8:00 – 9:00pm Singapore’s Growing Vibrant Biotech Ecosystem

    Piers Ingram, CEO, Hummingbird Bioscience

    XQ Lin, Group President & CEO, Esco Group; Chairman, EVX Ventures 

    Damian O’Connell, CEO, Experimental Therapeutics Development Centre, A*STAR

    Khoo Shih, Managing Director, Life Sciences Investments, Temasek

    Session Leader: Danny Soon, CEO, Consortium for Clinical Research and Innovation Singapore


    9:00 – 10:00pm Israel: The Startup Nation 2.0

    David Aviezer, Chairman, MetaboMed and FRONT BioPharma; Associate Professor, Adjunct, Bar-Ilan University

    Anya Eldan, VP of Innovation Authority and Head of Startup Division 

    Leah Klapper, CTO, FutuRx

    Yanay Ofran, Founder & CEO, Biolojic Design

    Opher Shapira, CEO, Yeda R&D, The Weizmann Institute of Science

    Session Leader: Julian Adams, CEO, Gamida Cell


    10:00 – 10:10pm A Special Musical Tribute to Patients  

  • March 18, 08:00 AM - 10:20 PM Delivering Shared Health

    8:00 – 8:10am Welcome

    Steve Bates, CEO, UK BioIndustry Association


    8:10 – 8:35am What Can Healthcare Learn from the Tech Industry? 

    A Conversation between Vijay Pande, General Partner, Andreessen Horowitz

    and Edward Hu, Vice Chairman and Chief Investment Officer, WuXi AppTec


    8:35 – 9:25am Engineering the Future of Health

    Ram Aiyar, CEO, Korro Bio 

    Michael Curtis, President of R&D, eGenesis

    Yaron Daniely, Head of aMoon Alpha; Investment Lead, aMoon Velocity 

    Justin Kao, Venture Partner, Khosla Ventures

    Jason Kelly, Co-Founder and CEO, Ginkgo Bioworks

    Session Leader: Misti Ushio, CEO, TARA Biosystems


    9:25 – 9:50am Prevention. Prediction. Precision. 

    A Conversation between Laurie Glimcher, President & CEO, Dana-Farber Cancer Institute and Cyriac Roeding, Co-Founder & CEO, Earli


    9:50 – 10:15am Speed. Scale. System. 

    A Conversation between George Vradenburg, Convener, Global CEO Initiative on Alzheimer’s Disease; Co-Chair, Davos Alzheimer’s Collaborative; Chairman & Co-Founder, UsAgainstAlzheimer’s and Genya Dana, Head of Healthcare Transformation, World Economic Forum


    10:15 – 10:20am Closing Remarks

    Hui Cai, Forum Chair; VP and Head of Content Division, WuXi AppTec

Speakers
  • Hui Cai
    Hui Cai
    Forum Chair; VP and Head of Content Division, WuXi AppTec
  • Steve Yang
    Steve Yang
    Co-CEO, WuXi AppTec
  • Philip Ross
    Philip Ross
    Vice Chairman, Global Investment Banking, J.P. Morgan
  • James Bradner
    James Bradner
    President, Novartis Institutes for Biomedical Research
  • Andy Plump
    Andy Plump
    President of R&D, Takeda
  • Nisa Leung
    Nisa Leung
    Managing Partner, Qiming Ventures Partners
  • Kevin Looi
    Kevin Looi
    Managing Director and Head of Asia, GIC Private Equity
  • Leon Wang
    Leon Wang
    EVP of International & China President, AstraZeneca
  • Bernhardt Zeiher
    Bernhardt Zeiher
    CMO, Astellas Pharma
  • Dan Wang
    Dan Wang
    Head of Johnson & Johnson Innovation, Asia Pacific
  • Casper Breum
    Casper Breum
    Senior Advisor, Lundbeckfonden Ventures
  • Geert-Jan Mulder
    Geert-Jan Mulder
    Managing Partner, Forbion
  • Ena Prosser
    Ena Prosser
    Partner, Fountain Healthcare Partners
  • Rafaèle Tordjman
    Rafaèle Tordjman
    Founder & CEO, Jeito Capital
  • Mary Kerr
    Mary Kerr
    CEO, NeRRe Therapeutics
  • Jenny Yip
    Jenny Yip
    Managing Partner, Adjuvant Capital
  • Richard Soll
    Richard Soll
    Head of Boston Office and Senior Advisor of Strategic Initiatives, WuXi AppTec
  • Marianne De Backer
    Marianne De Backer
    Head of Strategy, BD&L and Member of the Pharmaceuticals Executive Committee, Bayer
  • Bernd Goergen
    Bernd Goergen
    Partner, High-Tech Gruenderfonds
  • Marcus Kostka
    Marcus Kostka
    CEO, Abalos Therapeutics
  • Ioannis Sapountzis
    Ioannis Sapountzis
    Corp. SVP and Global Head of BD&L, Boehringer Ingelheim
  • Caroline Xu
    Caroline Xu
    Co-Founder & CEO, ViGeneron
  • Ulf Grawunder
    Ulf Grawunder
    CEO, NBE Therapeutics
  • Chandra Leo
    Chandra Leo
    Investment Advisor, HBM Partners
  • Chris Martin
    Chris Martin
    CEO, Co-Founder & Director, ADC Therapeutics
  • Alex Mayweg
    Alex Mayweg
    Managing Director, Versant Ventures
  • Jordi Montserrat
    Jordi Montserrat
    Co-Founder & Managing Partner, Venturelab
  • Michael Altorfer
    Michael Altorfer
    CEO, Swiss Biotech Association
  • Kyoung Kim
    Kyoung Kim
    EVP, CHA Biotech
  • James Jungkue Lee
    James Jungkue Lee
    CEO, Bridge Biotherapeutics
  • Lauren Young-Mi Lee
    Lauren Young-Mi Lee
    SVP, Head of Global R&D Innovation, Hanmi Pharmaceuticals
  • Jin-San Yoo
    Jin-San Yoo
    President & CEO, PharmAbcine
  • Chris Kim
    Chris Kim
    Managing Director, Novatio Ventures
  • Sakae Asanuma
    Sakae Asanuma
    President, Taiho Ventures
  • Mayu Morishima
    Mayu Morishima
    Executive Officer & Biotech Lead Capitalist, Beyond Next Ventures
  • Haru Morita
    Haru Morita
    Chairman & CEO, Modalis Therapeutics
  • Mark Noguchi
    Mark Noguchi
    SVP and Head of Business Development, Chugai Pharmaceutical
  • Makoto (Mark) Ohori
    Makoto (Mark) Ohori
    Partner, UTokyo Innovation Platform
  • Aki Tobaru
    Aki Tobaru
    Partner, Remiges Ventures
  • Tai Harada
    Tai Harada
    Manager & VP of US Operation, Fast Track Initiative
  • Laurent Fraisse
    Laurent Fraisse
    R&D Director, Drugs for Neglected Diseases Initiative (DNDi)
  • Dave Madge
    Dave Madge
    VP of Research Service Division, WuXi AppTec
  • Julie Brady
    Julie Brady
    Business Development Manager for Drug Discovery, University of Dundee
  • Kathryn Chapman
    Kathryn Chapman
    Deputy Director, Milner Therapeutics Institute, University of Cambridge
  • Chris Molloy
    Chris Molloy
    CEO, Medicines Discovery Catapult
  • James Naismith
    James Naismith
    Director, Rosalind Franklin Institute; Professor, Structural Biology, University of Oxford
  • Ian Tomlinson
    Ian Tomlinson
    Chairman, Apollo Therapeutics; Chairman, Start Codon
  • Martin Shanahan
    Martin Shanahan
    CEO, IDA Ireland
  • Barry Heavey
    Barry Heavey
    Managing Director, Accenture Life Sciences
  • Darrin Morrissey
    Darrin Morrissey
    Chief Executive of the National Institute for Bioprocessing Research and Training, Ireland
  • Emmanuel Dowdall
    Emmanuel Dowdall
    Global EVP and CEO Asia Pacific, IDA Ireland
  • Piers Ingram
    Piers Ingram
    CEO, Hummingbird Bioscience
  • XQ Lin
    XQ Lin
    Group President & CEO, Esco Group; Chairman, EVX Ventures
  • Damian O’Connell
    Damian O’Connell
    CEO, Experimental Therapeutics Development Centre, A*STAR
  • Khoo Shih
    Khoo Shih
    Managing Director, Life Sciences Investments, Temasek
  • Danny Soon
    Danny Soon
    CEO, Consortium for Clinical Research and Innovation Singapore
  • David Aviezer
    David Aviezer
    Chairman, MetaboMed and FRONT BioPharma; Associate Professor, Adjunct, Bar-Ilan University
  • Anya Eldan
    Anya Eldan
    VP of Innovation Authority and Head of Startup Division
  • Leah Klapper
    Leah Klapper
    CTO, FutuRx
  • Yanay Ofran
    Yanay Ofran
    Founder & CEO, Biolojic Design
  • Opher Shapira
    Opher Shapira
    CEO, Yeda R&D, The Weizmann Institute of Science
  • Julian Adams
    Julian Adams
    CEO, Gamida Cell
  • Steve Bates
    Steve Bates
    CEO, UK BioIndustry Association
  • Vijay Pande
    Vijay Pande
    General Partner, Andreessen Horowitz
  • Edward Hu
    Edward Hu
    Vice Chairman and Chief Investment Officer, WuXi AppTec
  • Ram Aiyar
    Ram Aiyar
    CEO, Korro Bio
  • Michael Curtis
    Michael Curtis
    President of R&D, eGenesis
  • Yaron Daniely
    Yaron Daniely
    Head of aMoon Alpha; Investment Lead, aMoon Velocity
  • Justin Kao
    Justin Kao
    Venture Partner, Khosla Ventures
  • Jason Kelly
    Jason Kelly
    Co-Founder and CEO, Ginkgo Bioworks
  • Misti Ushio
    Misti Ushio
    CEO, TARA Biosystems
  • Laurie Glimcher
    Laurie Glimcher
    President & CEO, Dana-Farber Cancer Institute
  •  Cyriac Roeding
    Cyriac Roeding
    Co-Founder & CEO, Earli
  • George Vradenburg
    George Vradenburg
    Convener, Global CEO Initiative on Alzheimer’s Disease; Co-Chair, Davos Alzheimer’s Collaborative; Chairman & Co-Founder, UsAgainstAlzheimer’s
  • Genya Dana
    Genya Dana
    Head of Healthcare Transformation, World Economic Forum

EVENTS

wuxi-executive-breakfast-in-basel-the-most-important-innovation-in-drug-r-d-may-be-how-the-industry-works-together
WuXi Executive Breakfast in Basel: The Most Important Innovation in Drug R&D May Be How the Industry Works Together
Reflections from the WuXi Executive Breakfast at Swiss Biotech Day
May 11, 2026
READ MORE

FEATURED

© 2026 WuXi AppTec. All Rights Reserved.Privacy Policy